NONSMALL CELL LUNG CANCER, STAGE II

Clinical trials for NONSMALL CELL LUNG CANCER, STAGE II explained in plain language.

Never miss a new study

Get alerted when new NONSMALL CELL LUNG CANCER, STAGE II trials appear

Sign up with your email to follow new studies for NONSMALL CELL LUNG CANCER, STAGE II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Race against time: can starting cancer drug sooner save more lives?

Disease control Recruiting now

This study is testing whether starting an immunotherapy drug called durvalumab sooner after finishing chemotherapy and radiation can better control stage III lung cancer. Researchers want to see if starting treatment within 14 days (instead of the usual longer wait) is safe, effe…

Matched conditions: NONSMALL CELL LUNG CANCER, STAGE II

Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control

Last updated Mar 16, 2026 15:25 UTC

NONSMALL CELL LUNG CANCER, STAGE II

Get alerted when new NONSMALL CELL LUNG CANCER, STAGE II trials appear

Race against time: can starting cancer drug sooner save more lives?